151
|
Palta R, McClune A, Esrason K. Hodgkin’s lymphoma coexisting with liver failure secondary to acute on chronic hepatitis B. World J Clin Cases 2013; 1:37-40. [PMID: 24303460 PMCID: PMC3845923 DOI: 10.12998/wjcc.v1.i1.37] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/13/2013] [Accepted: 04/02/2013] [Indexed: 02/05/2023] Open
Abstract
Acute on chronic liver failure (ACLF) is rarely the initial manifestation of a malignant process or precipitated by the initiation of anti-viral treatment with a nucleoside or nucleotide agent. We report an unusual case of ACLF temporally associated with initiation of Entecavir for treatment of chronic hepatitis B. Early Hodgkin’s lymphoma (HL) was unmasked with initiation of the anti-viral treatment which may have exacerbated ACLF. To the best of our knowledge, this has not been described in the literature. In reviewing our patients clinical course and liver autopsy, he developed a severe acute exacerbation of his chronic hepatitis B virus coinciding with the institution of antiviral therapy and the underlying HL perhaps modulating the overall degree of hepatic injury.
Collapse
|
152
|
Zekri ARN, Bahnasy AA, Shoeab FEM, Mohamed WS, El-Dahshan DH, Ali FT, Sabry GM, Dasgupta N, Daoud SS. Methylation of multiple genes in hepatitis C virus associated hepatocellular carcinoma. J Adv Res 2013; 5:27-40. [PMID: 25685469 PMCID: PMC4294722 DOI: 10.1016/j.jare.2012.11.002] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2012] [Revised: 11/06/2012] [Accepted: 11/06/2012] [Indexed: 02/08/2023] Open
Abstract
We studied promoter methylation (PM) of 11 genes in Peripheral Blood Lymphocytes (PBLs) and tissues of hepatitis C virus (HCV) associated hepatocellular carcinoma (HCC) and chronic hepatitis (CH) Egyptian patients. The present study included 31 HCC with their ANT, 38 CH and 13 normal hepatic tissue (NHT) samples. In all groups, PM of APC, FHIT, p15, p73, p14, p16, DAPK1, CDH1, RARβ, RASSF1A, O6MGMT was assessed by methylation-specific PCR (MSP). APC and O6-MGMT protein expression was assessed by immunohistochemistry (IHC) in the studied HCC and CH (20 samples each) as well as in a different HCC and CH set for confirmation of MSP results. PM was associated with progression from CH to HCC. Most genes showed high methylation frequency (MF) and the methylation index (MI) increased with disease progression. MF of p14, p73, RASSF1A, CDH1 and O6MGMT was significantly higher in HCC and their ANT. MF of APC was higher in CH. We reported high concordance between MF in HCC and their ANT, MF in PBL and CH tissues as well as between PM and protein expression of APC and O6MGMT. A panel of 4 genes (APC, p73, p14, O6MGMT) classifies the cases independently into HCC and CH with high accuracy (89.9%), sensitivity (83.9%) and specificity (94.7%). HCV infection may contribute to hepatocarcinogenesis through enhancing PM of multiple genes. PM of APC occurs early in the cascade while PM of p14, p73, RASSF1A, RARB, CDH1 and O6MGMT are late changes. A panel of APC, p73, p14, O6-MGMT could be used in monitoring CH patients for early detection of HCC. Also, we found that, the methylation status is not significantly affected by whether the tissue was from the liver or PBL, indicating the possibility of use PBL as indicator to genetic profile instead of liver tissue regardless the stage of disease.
Collapse
Affiliation(s)
- Abdel-Rahman N Zekri
- Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Egypt
| | - Abeer A Bahnasy
- Pathology Department, National Cancer Institute, Cairo University, Egypt
| | | | - Waleed S Mohamed
- Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Egypt
| | | | - Fahmey T Ali
- Faculty of Science, Ain Shams, University, Egypt
| | | | - Nairajana Dasgupta
- Center for Integrated Biotechnology, Washington State University, Pullman, WA, United States
| | - Sayed S Daoud
- Center for Integrated Biotechnology, Washington State University, Pullman, WA, United States
| |
Collapse
|
153
|
Kwon SH, Jeong SW, Jang JY, Lee JE, Lee SH, Kim SG, Kim YS, Cho YD, Kim HS, Kim BS, Jin SY. Cyclooxygenase-2 and vascular endothelial growth factor in chronic hepatitis, cirrhosis and hepatocellular carcinoma. Clin Mol Hepatol 2012; 18:287-94. [PMID: 23091809 PMCID: PMC3467432 DOI: 10.3350/cmh.2012.18.3.287] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/09/2012] [Revised: 08/06/2012] [Accepted: 08/09/2012] [Indexed: 01/05/2023] Open
Abstract
Background/Aims Cyclooxygenase-2 (COX-2) and vascular endothelial growth factor (VEGF) are up-regulated in hepatocellular carcinoma (HCC). To investigate the levels of COX-2 and VEGF expression in chronic hepatitis (CH), cirrhosis, and HCC. Methods The immunohistochemical expressions of COX-2 and VEGF were evaluated in tissues from patients with CH (n=95), cirrhosis (n=38), low-grade HCC (LG-HCC; n=6), and high-grade HCC (HG-HCC; n=29). Results The COX-2 expression scores in CH, cirrhosis, LG-HCC, and HG-HCC were 3.3±1.9 (mean±SD), 4.2±1.7, 5.5±1.0, and 3.4±2.4, respectively (CH vs. cirrhosis, P=0.016; CH vs. LG-HCC, P=0.008; LG-HCC vs. HG-HCC, P=0.004), and the corresponding VEGF expression scores were 0.9±0.8, 1.5±0.7, 1.8±0.9, and 1.6±1.1 (CH vs. cirrhosis, P<0.001; CH vs. LG-HCC, P=0.011; LG-HCC vs. HG-HCC, P=0.075). Both factors were correlated with the fibrosis stage in CH and cirrhosis (COX-2: r=0.427, P<0.001; VEGF: r=0.491, P<0.001). There was a significant correlation between COX-2 and VEGF in all of the tissue samples (r=0.648, P<0.001), and between high COX-2 and VEGF expression scores and survival (COX-2: P=0.001; VEGF: P<0.001). Conclusions The expressions of both COX-2 and VEGF are significantly higher in cirrhosis and LG-HCC than in CH. High COX-2 and high VEGF expressions are associated with a high survival rate.
Collapse
Affiliation(s)
- Soon Ha Kwon
- Division of Gastroenterology, Department of Internal Medicine, Soonchunhyang University College of Medicine, Seoul, Korea
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
154
|
Neri S, Signorelli SS, Scuderi R, Bruno M, Bertino G, Clementi A, Torrisi I, Fidone F, Pagano AB, Malaguarnera M, Noto R. Carotid intima-media thickness and liver histology in hemodialysis patients with nonalcoholic Fatty liver disease. Int J Angiol 2012; 20:149-56. [PMID: 22942630 DOI: 10.1055/s-0031-1283218] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023] Open
Abstract
The prevalence of atherosclerotic cardiovascular disease in chronic hemodialysis (HD) patients has been demonstrated to be higher than in healthy people. Severe liver fibrosis is strongly associated with early carotid atherosclerosis and it might reduce the survival of patients who undergo both renal replacement therapy and transplantation. We wanted to assess whether nonalcoholic fatty liver disease (NAFLD) was associated with altered intima-media thickness (IMT) in HD patients as an independent marker of subclinical atherosclerosis. We enrolled 42 patients undergoing HD and 48 patients with normal renal function, all of them with high levels of aminotransferases and an ultrasonographic diagnosis of liver steatosis. The control group consisted of 60 healthy subjects. Laboratory tests for inflammatory and oxidative markers, ultrasonographic liver evaluation, carotid IMT measurement, and liver biopsy were performed. Different degrees of fibrosis were detected in our study cohort. Worse liver histopathological scores and higher plasmatic levels of C-reactive protein, reactive oxygen species, and vascular cell adhesion molecule-1 were found in HD patients. Carotid IMT was significantly higher (p < 0.005) in patients with histological steatosis. HD patients may develop active and progressive chronic hepatitis faster than patients with normal renal function and the thickness of their carotid intima-media might be markedly increased. These two conditions seem to be independent on classical risk factors and on metabolic syndrome. They might be related to the high levels of oxidants and to the inflammatory state, which are typical of patients undergoing HD. Independently related with the traditional risk factors for cardiovascular disease, nonspecific inflammation and oxide-reductive imbalance may play an important role in the progression of NAFLD and atherosclerotic disease in HD patients.
Collapse
|
155
|
Cieśla A, Kuśmider M, Faron-Górecka A, Dziedzicka-Wasylewska M, Bociąga-Jasik M, Owczarek D, Ciećko-Michalska I, Cibor D, Mach T. Intrahepatic expression of genes related to metabotropic receptors in chronic hepatitis. World J Gastroenterol 2012; 18:4156-61. [PMID: 22919248 PMCID: PMC3422796 DOI: 10.3748/wjg.v18.i31.4156] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/01/2011] [Revised: 04/23/2012] [Accepted: 04/27/2012] [Indexed: 02/06/2023] Open
Abstract
AIM: To screen for genes related to metabotropic receptors that might be involved in the development of chronic hepatitis.
METHODS: Assessment of 20 genes associated with metabotropic receptors was performed in liver specimens obtained by punch biopsy from 12 patients with autoimmune and chronic hepatitis type B and C. For this purpose, a microarray with low integrity grade and with oligonucleotide DNA probes complementary to target transcripts was used. Evaluation of gene expression was performed in relation to transcript level, correlation between samples and grouping of clinical parameters used in chronic hepatitis assessment. Clinical markers of chronic hepatitis included alanine and aspartate aminotransferase, γ-glutamyltranspeptidase, alkaline phosphatase and cholinesterase activity, levels of iron ions, total cholesterol, triglycerides, albumin, glucose, hemoglobin, platelets, histological analysis of inflammatory and necrotic status, fibrosis according to METAVIR score, steatosis, as well as anthropometric body mass index, waist/hip index, percentage of adipose tissue and liver size in ultrasound examination. Gender, age, concomitant diseases and drugs were also taken into account. Validation of oligonucleotide microarray gene expression results was done with the use of quantitative real-time polymerase chain reaction (qRT-PCR).
RESULTS: The highest (0.002 < P < 0.046) expression among genes encoding main components of metabotropic receptor pathways, such as the α subunit of G-coupled protein, phosphoinositol-dependent protein kinase or arrestin was comparable to that of angiotensinogen synthesized in the liver. Carcinogenesis suppressor genes, such as chemokine ligand 4, transcription factor early growth response protein 1 and lysophosphatidic acid receptor, were characterized by the lowest expression (0.002 < P < 0.046), while the factor potentially triggering hepatic cancer, transcription factor JUN-B, had a 20-fold higher expression. The correlation between expression of genes of protein kinases PDPK1, phosphoinositide 3-kinase and protein kinase A (Spearman’s coefficient range: 0.762-0.769) confirmed a functional link between these enzymes. Gender (P = 0.0046) and inflammation severity, measured by alanine aminotransferase activity (P = 0.035), were characterized by diverse metabotropic receptor gene expression patterns. The Pearson’s coefficient ranging from -0.35 to 0.99 from the results of qRT-PCR and microarray indicated that qRT-PCR had certain limitations as a validation tool for oligonucleotide microarray studies.
CONCLUSION: A microarray-based analysis of hepatocyte metabotropic G-protein-related gene expression can reveal the molecular basis of chronic hepatitis.
Collapse
|
156
|
Zhang T, Xu XY, Zhou H, Zhao X, Song M, Zhang TT, Yin H, Li T, Li PT, Cai DY. A pharmacodynamic model of portal hypertension in isolated perfused rat liver. World J Gastroenterol 2012; 18:472-8. [PMID: 22346254 PMCID: PMC3270509 DOI: 10.3748/wjg.v18.i5.472] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/22/2011] [Revised: 06/30/2011] [Accepted: 07/07/2011] [Indexed: 02/06/2023] Open
Abstract
AIM To develop a pharmacodynamic model of portal hypertension from chronic hepatitis. METHODS Pathological changes and collagen depositions were analyzed using morphometry to confirm CCl₄-induced chronic hepatitis. At d₀, d₂₈, d₅₆ and d₈₄ of the process, the portal perfused velocities (μL/min) in isolated rat livers were exactly controlled with a quantified pump. The pressure (mmHg) was monitored with a Physiological System. The geometric concentrations of phenylephrine or acetylcholine were added to a fixed volume (300 mL) of the circulating perfusate. The equation, the median effective concentration and its 95% confidence intervals of phenylephrine or acetylcholine were regressed with Prism-4 software in non-linear fit and various slopes. In the isolated perfused rat livers with chronic hepatitis, both median effective concentrations were defined as the pharmacodynamic model of portal hypertension. RESULTS At d₀, d₂₈, d₅₆ and d₈₄, the equations of portal pressure potency from the concentrations of phenylephrine used to constrict the portal vein in isolated perfused rat livers were Y = 0.1732 + 0.3970/[1 + 10((-4.3061-0.4407 X))], Y = -0.004934 + 0.12113/[1 + 10((-3.1247-0.3262 X))], Y = 0.0104 + 0.2643/[1 + 10((-8.8462-0.9579 X))], and Y = 0.01603 + 0.12107/[1 + 10((-5.1134-0.563 X))]; the median effective concentrations were 1.69 × 10⁻¹⁰ mol/L, 2.64 × 10⁻¹⁰ mol/L, 5.82 × 10⁻¹⁰ mol/L, and 8.24 × 10⁻¹⁰ mol/L, respectively. The equations from the concentrations of acetylcholine used to relax the portal vein were Y = -0.4548 + 0.3274/[1 + 10((6.1538 + 0.5554 X))], Y = -0.05391 + 0.06424/[1 + 10((3.8541 + 0.3469 X))], Y = -0.2733 + 0.22978/[1 + 10((3.0472 + 0.3008 X))], and Y = -0.0559 + 0.053178/[1 + 10((5.6336 + 0.5883 X))]; the median effective concentrations were 8.40 × 10⁻¹⁰ mol/L, 7.73 × 10⁻¹² mol/L, 5.98 × 10⁻¹¹ mol/L, and 2.66 × 10⁻¹⁰ mol/L, respectively. CONCLUSION A pharmacodynamic model of portal hypertension in isolated perfused rat livers with chronic hepatitis was defined as the median effective concentrations of phenylephrine and acetylcholine.
Collapse
|
157
|
Lahiri KK, Sahni AK, Gupta RM, Duhan SD, Kapila K, Jena J. Hepatitis B e Antigen Negative Chronic Hepatitis in Indian Patients : A Reality. Med J Armed Forces India 2011; 63:318-21. [PMID: 27408038 DOI: 10.1016/s0377-1237(07)80004-9] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2005] [Accepted: 10/13/2006] [Indexed: 10/18/2022] Open
Abstract
BACKGROUND Hepatitis B e antigen negative chronic hepatitis (e(-) CHB) with detectable levels of hepatitis B virus DNA (HBV DNA) in serum has been reported in cases from Asia. This study was undertaken to find out prevalence e(-)CHB and to correlate its presence with the clinical status and severity of the illness in cases of chronic liver disease in India. METHODS All patients of infective hepatitis, who were hepatitis B surface antigen (HBsAg) positive by enzyme-linked immunosorbent assay (ELISA), were evaluated with liver function tests and HBeAg and antiHBe antibody studies. Polymerase chain reaction (PCR) test was carried out to detect HBV DNA qualitatively. RESULT Out of 2064 samples tested by ELISA, 429 (20.78 %) were HBsAg positive. HBV DNA (qualitative) was performed on all 429 patients and 74 (17.2%) were HBV DNA positive. Of these only 42 (56.75 %) tested positive for HBeAg. Overall, 8.3 % of HBeAg negative patients (32/384) were viraemic with evidence of chronic liver disease/clinical cirrhosis and alteration of transaminase levels, while three cases (0.84 %) HBeAg positive cases did not show presence of HBV DNA. CONCLUSION This study shows e(-)CHB prevalence rate of 8.3% in patients with HBV infection in India. Since HBeAg negative patients had detectable levels of HBV DNA as seen in HBeAg positive patients, benefit of antiviral therapy should be given to them. Population studies on e(-) CHB cases are needed to determine its true prevalence, natural course and response to therapy.
Collapse
Affiliation(s)
- K K Lahiri
- Associate Professor, Armed Forces Medical College, Pune
| | - A K Sahni
- Senior Advisor (Microbiology), Base Hospital Delhi Cantt
| | - R M Gupta
- Reader, Armed Forces Medical College, Pune
| | - S D Duhan
- Associate Professor (Department of Internal Medicine), Armed Forces Medical College, Pune
| | - K Kapila
- Professor and Head (Department of Microbiology), Armed Forces Medical College, Pune
| | - J Jena
- ADMS Headquarters, Eastern Command, Kolkata
| |
Collapse
|
158
|
Adler M. Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI). Hepat Mon 2011; 11:565-6. [PMID: 22087196 PMCID: PMC3212760] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Download PDF] [Subscribe] [Scholar Register] [Received: 02/06/2011] [Revised: 06/20/2011] [Accepted: 06/24/2011] [Indexed: 12/03/2022]
Affiliation(s)
- Michael Adler
- Department of Gastroenterology, Hepato-Pancreatology and Digestive Oncology, Erasmus Hospital Brussels, Brussels, Belgium,Corresponding author at: Michael Adler, Department of Gastroenterology,Hepato-Pancreatology and Digestive Oncology Erasmus Hospital Brussels,808 route de Lennik, 1070, Brussels, Belgium. Tel.: +32-25553714, E-mail:
| |
Collapse
|
159
|
Sirli R, Sporea I. Aspartate aminotransferase to platelet ratio index for the assessment of liver fibrosis severity in patients with chronic hepatitis. Hepat Mon 2011; 11:560-1. [PMID: 22087195 PMCID: PMC3212765] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Download PDF] [Subscribe] [Scholar Register] [Received: 04/09/2011] [Revised: 04/12/2011] [Accepted: 04/15/2011] [Indexed: 12/11/2022]
Affiliation(s)
- Roxana Sirli
- Department of Gastroenterology, University of Medicine and Pharmacy, Timisoara, Romania,Corresponding author at: Roxana Sirli, Department of Gastroenterology,University of Medicine and Pharmacy, Timisoara, Romania, P.O. Box: 14,Sirius str., ap.5 300688, Timisoara, Romania. Tel.: +40-723537039, Fax: +40-256488003, E-mail:
| | - Ioan Sporea
- Department of Hepatology, University of Medicine and Pharmacy, Timisoara, Romania
| |
Collapse
|
160
|
Zhang KH, Miu XL, Wu SM. Changes in plasma levels of soluble E-selectin, T lymphocyte subsets and NK cells in patients with chronic HBV infection. Shijie Huaren Xiaohua Zazhi 2011; 19:1892-1898. [DOI: 10.11569/wcjd.v19.i18.1892] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/07/2023] Open
Abstract
AIM: To evaluate serum and hepatic levels of E-selectin in patients with chronic HBV infection and to analyze their relationship with T lymphocyte subsets and natural killer (NK) cells.
METHODS: Serum samples from 270 patients with chronic HBV infection, including 101 patients with chronic hepatitis, 121 with liver cirrhosis and 48 with hepatocellular carcinoma, and from 281 healthy controls, were used in this study. Circulating levels of soluble E-selectin were measured by enzyme-linked immunosorbent assay (ELISA). T lymphocyte subsets and NK cells were measured by flow cytometry (FCM). Immunohistochemistry (IHC) was used to detect the expression of E-selectin in liver tissue specimens from patients with chronic HBV infection.
RESULTS: Serum levels of soluble E-selectin were higher in patients with chronic hepatitis or liver cirrhosis than in those with hepatocellular carcinoma and healthy controls (68.94 ± 34.09, 43.39 ± 18.00 vs 16.69 ± 8.27, 13.96 ± 7.50, all P < 0.01). Immunohistochemistry analysis showed that the positive rates of E-selectin expression in endothelial cells in patients with chronic hepatitis and those with liver cirrhosis were 83.3% and 57.1% (χ2 = 6.242, P = 0.012), respectively, and no positive E-selectin staining was detected in patients with hepatocellular carcinoma or healthy controls. The percentages of CD4+ T cells and NK cells decreased significantly in patients with chronic HBV infection than in controls (29.11 ± 6.79 vs 37.02 ± 7.05; 23.57 ± 7.33 vs 27.37 ± 7.03, both P < 0.01). The percentages of CD3+, CD8+, CD4+ T cells and NK cells decreased significantly in patients with liver cirrhosis or hepatocellular carcinoma than in controls (all P < 0.01). Soluble E-selectin levels were positively related to the percentages of CD3+ and CD8+ cells (r = 0.548, 0.715; both P < 0.01), but negatively related to the percentages of CD4+ cells and NK cells (r = -0.429, -0.672; both P < 0.01).
CONCLUSION: Varying degrees of immune dysfunction is present in patients with chronic HBV infection, and high expression of E-selectin is associated with the development of chronic hepatitis and liver cirrhosis. These results suggest that E-selectin can be used as a useful marker for evaluation of hepatic inflammatory activity.
Collapse
|
161
|
Papageorgiou MV, Papatheodoridis GV, Manolakopoulos S, Tsochatzis E, Kranidioti H, Kafiri G, Archimandritis AI. Elastography for hepatic fibrosis severity in chronic hepatitis B or C. Case Rep Gastroenterol 2011; 5:63-72. [PMID: 21526140 PMCID: PMC3082481 DOI: 10.1159/000316635] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/26/2022] Open
Abstract
Aims To assess the value of transient elastography for predicting significant fibrosis or cirrhosis in chronic hepatitis B or C (CHB or CHC) patients. Methods 75 patients (CHB: 45, CHC: 32) were included. All underwent elastography and liver biopsy concurrently. Biopsies were evaluated using Ishak's classification. Fibrosis was mild, moderate or severe/cirrhosis when scores were 0–1 (n = 30), 2–3 (n = 20), 4–6 (n = 25), respectively. Results Median liver stiffness values were higher in patients with severe fibrosis or cirrhosis than in those with moderate or mild fibrosis (14.8 vs. 6.4 vs. 5.3 kPa, p < 0.001). The diagnostic accuracy of elastography for severe fibrosis and cirrhosis was excellent [area under the receiver operating characteristic (AUROC) curve 0.938 vs. 0.948], but it was not optimal for mild fibrosis (AUROC 0.78). Values of 7.5, 9.0 and 12 kPa had a sensitivity and specificity for severe fibrosis/cirrhosis of 96, 84 and 60%, and 76, 90 and 94%, respectively. The median stiffness value in cirrhotic patients (score 5–6) was 16.6 kPa (7.7–48). No differences in accuracy of elastography between CHB or CHC patients were found. Cutoff was 12.5 kPa for cirrhosis; 10/75 patients (13%) were misclassified. Conclusion Transient elastography has an excellent diagnostic accuracy for severe fibrosis and cirrhosis in CHB and CHC, but the cutoffs need further evaluation.
Collapse
|
162
|
El-Shabrawi MHF, El-Raziky M, Sheiba M, El-Karaksy HM, El-Raziky M, Hassanin F, Ramadan A. Value of duplex doppler ultrasonography in non-invasive assessment of children with chronic liver disease. World J Gastroenterol 2010; 16:6139-44. [PMID: 21182231 PMCID: PMC3012578 DOI: 10.3748/wjg.v16.i48.6139] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
AIM: To investigate the value of duplex Doppler ultrasonography (US) in the assessment of the hemodynamics of the portal and hepatic veins in a cohort of children with chronic liver disease (CLD) and to detect any relationship between the US changes, etiology and severity (or stage) of CLD.
METHODS: We prospectively enrolled 25 children with biopsy-proven CLD. Thirteen had cirrhosis (aged 8.9 ± 2.0 years) and 12 had chronic hepatitis (aged 9.3 ± 2.3 years). Gray scale and color-coded duplex Doppler US were performed for all, as well as 30 healthy age and sex-matched controls. Findings were correlated with clinical, laboratory and histopathological characteristics.
RESULTS: Prominent caudate lobe was detected in 100% of cirrhotics, but none of the chronic hepatitis or controls. Thickened lesser omentum and loss of the triphasic waveform of the hepatic vein were present in 69.2% and 53.8% of cirrhotics vs 33.3% and 8.3% of chronic hepatitis respectively. Portal vein flow velocity was significantly lower (P < 0.0001) and the congestion index was significantly higher (P < 0.005) in both patient groups compared to controls. Child-Pugh’s staging showed a positive correlation with both abnormal hepatic vein waveform and direction of portal blood flow; and a negative correlation with both hepatic and portal vein flow velocities. No correlation with the etiology of CLD could be detected.
CONCLUSION: Duplex Doppler added to grayscale US can detect significant morphologic and portal hemodynamic changes that correlate with the severity (stage) of CLD, but not with etiology.
Collapse
|
163
|
Abstract
The Epstein-Barr virus (EBV) has an important and multifaceted role in liver pathology. As a member of the herpes virus family, EBV establishes a persistent infection in more than 90% of adults. Besides acute hepatitis during primary infection, many clinical syndromes of interest for the hepatologist are associated with EBV infection. The role of EBV in the evolution of chronic hepatitis from hepatotropic viruses is considered. Chronic EBV-associated hepatitis is suspected in immunocompetent adults with compatible serology, suggestive histology and detection of the viral genome in the liver and/or increase of specific circulating cytotoxic T-lymphocytes. EBV is the main cause of post-transplant lymphoproliferative disorders which occur in up to 30% of cases. EBV-driven lymphoproliferative diseases are also recognized in non-immunocompromised patients and liver is involved in up to a third of the cases. Directly implicated in the pathogenesis of different tumors, EBV has a disputable role in hepatocellular carcinoma carcinogenesis. Further research is required in order to establish or reject the role of EBV in human liver cancer. This paper attempts to discuss the range of EBV-associated chronic liver diseases in immunocompetent patients, from mild, self-limiting mononuclear hepatitis to liver cancer.
Collapse
|
164
|
Galizzi F J, Teixeira R, Fonseca JCF, Souto FJD. Clinical profile of hepatitis B virus chronic infection in patients of Brazilian liver reference units. Hepatol Int 2010; 4:511-5. [PMID: 20827409 DOI: 10.1007/s12072-010-9178-2] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/09/2009] [Accepted: 03/05/2010] [Indexed: 01/04/2023]
Abstract
PURPOSE To assess data about chronic forms of hepatitis B virus (HBV) infection in Brazilian reference units, the Brazilian Society of Hepatology (SBH) performed a survey, with its associates spread throughout the country. METHODS SBH members were contacted by electronic mail. They were asked for data from their liver units regarding chronically infected HBV patients between January 2005 and September 2007. All subjects with HBV surface antigenemia lasting more than 6 months were eligible. Patients who died after January 2005 were also included. RESULTS Data from 24 units of 17 cities (12 Brazilian states) were obtained. These corresponded to 3,913 patients. Mean age was 39 years, ranging from 1 to 84 years. The northern region had the lowest mean age (35 years) and the southern region the highest (43 years). Most of the sampled people were white; 1,448 of 3,614 patients had chronic hepatitis B. Most of them were HBeAg negative (1.4:1). There were 1,695 (46.9%) inactive carriers of 3,614 HBV-infected patients and other 69 (1.9%) were considered as having immune-tolerant status. Hepatitis D coinfection was common among the Amazonian sample (n = 369). CONCLUSIONS This large sample study shows important tendencies of chronic hepatitis B infection in Brazilian reference units, such as HBeAg-negative chronic hepatitis B cases overwhelming wild-type strains infected cases. Besides, hepatitis D occurs only among the Amazonian patients.
Collapse
|
165
|
Wang ZF, Song SH, Wang YZ, Song BB, Men NN, Meng DY. Cluster analysis of traditional Chinese medicine symptoms and pathological staging of liver fibrosis in chronic hepatitis. Shijie Huaren Xiaohua Zazhi 2010; 18:1157-1162. [DOI: 10.11569/wcjd.v18.i11.1157] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
AIM: To perform a cluster analysis of traditional Chinese medicine (TCM) symptoms of liver fibrosis in chronic hepatitis and to explore the relevance between TCM syndromes and pathological stages of liver fibrosis.
METHODS: A total of 285 patients with chronic hepatitis and liver fibrosis in three centers were included in the study. Liver fibrosis was graded by histopathological examination. TCM symptoms were observed. Dimensionality reduction and clustering of TCM symptoms were performed using a clustering method. By selecting appropriate locations as interception points, TCM syndromes were precipitated. A simple correspondence analysis was then performed to evaluate the relevance between TCM syndromes and pathological stages of liver fibrosis.
RESULTS: Forty-four TCM symptoms were clustered into five syndromes: liver Qi stagnation and spleen deficiency, internal accumulation of damp-heat, Qi stagnation and blood stasis, Qi-Yin deficiency, and liver and kidney Yin deficiency. TCM syndromes are closely related with the pathological stages of liver fibrosis (χ2 = 33.998, P = 0.005). The inertia values of dimensions 1, 2 and 3 were 0.084, 0.022 and 0.011, respectively, while the contribution rates were 70.6%, 18.7% and 9.2%, respectively. Liver Qi stagnation and spleen deficiency, internal accumulation of damp-heat, Qi stagnation and blood stasis, Qi-Yin deficiency, and liver and kidney Yin deficiency were frequently seen in stage S0, S1, S2, S3, and S4 liver fibrosis, respectively.
CONCLUSION: TCM syndrome is closely correlated with the degree of liver fibrosis. TCM syndrome is aggravated with the progression of liver fibrosis.
Collapse
|
166
|
Tong MJ, Hsu L, Hsien C, Kao JH, Durazo FA, Saab S, Blatt LM. A comparison of hepatitis B viral markers of patients in different clinical stages of chronic infection. Hepatol Int 2010; 4:516-22. [PMID: 20827410 PMCID: PMC2896649 DOI: 10.1007/s12072-010-9179-1] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/30/2009] [Accepted: 03/05/2010] [Indexed: 12/22/2022]
Abstract
Purpose Hepatitis B viral markers may be useful for predicting outcomes such as liver-related deaths or development of hepatocellular carcinoma. We determined the frequency of these markers in different clinical stages of chronic hepatitis B infection. Methods We compared baseline hepatitis B viral markers in 317 patients who were enrolled in a prospective study and identified the frequency of these tests in immune-tolerant (IT) patients, in inactive carriers, and in patients with either hepatitis B e antigen (HBeAg)-positive or HBeAg-negative chronic hepatitis or cirrhosis. Results IT patients were youngest (median age 27 years) and HBeAg-negative patients with cirrhosis were oldest (median age 58 years) (p = 0.03 to <0.0001). The male to female ratio was similar both in IT patients and in inactive carriers, but there was a male preponderance both in patients with chronic hepatitis and in patients with cirrhosis (p < 0.0001). The A1896 precore mutants were most prevalent in inactive carriers (36.4%) and HBeAg-negative patients with chronic hepatitis (38.8%; p < 0.0001), and the T1762/A1764 basal core promoter mutants were most often detected in HBeAg-negative patients with cirrhosis (65.1%; p = 0.02). Genotype A was detected only in 5.3% of IT patients, and genotype B was least often detected in both HBeAg-Positive patients with chronic hepatitis and cirrhosis (p = 0.03). The hepatitis B viral DNA levels were lowest in inactive carriers (2.69 log10 IU/mL) and highest in IT patients (6.80 log10 IU/mL; p = 0.02 to <0.0001). At follow-up, HBeAg-positive and HBeAg-negative patients with cirrhosis accounted for 57 of 64 (89.1%) liver-related deaths (p < 0.0001). Conclusion Differences in baseline hepatitis B viral markers were detected in patients in various clinical stages of hepatitis B virus infection. HBeAg-positive and HBeAg-negative patients with cirrhosis accounted for the majority of the liver-related fatalities.
Collapse
Affiliation(s)
- Myron John Tong
- Division of Digestive Diseases, The Pfleger Liver Institute, David Geffen School of Medicine, University of California in Los Angeles, Los Angeles, CA USA
- The Liver Center, Huntington Medical Research Institutes, 660 S. Fair Oaks Ave, Pasadena, CA 91105 USA
| | - Leeyen Hsu
- The Liver Center, Huntington Medical Research Institutes, 660 S. Fair Oaks Ave, Pasadena, CA 91105 USA
| | - Carlos Hsien
- The Liver Center, Huntington Medical Research Institutes, 660 S. Fair Oaks Ave, Pasadena, CA 91105 USA
| | - Jia-Horng Kao
- Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan
| | - Francisco Antonio Durazo
- Division of Digestive Diseases, The Pfleger Liver Institute, David Geffen School of Medicine, University of California in Los Angeles, Los Angeles, CA USA
| | - Sammy Saab
- Division of Digestive Diseases, The Pfleger Liver Institute, David Geffen School of Medicine, University of California in Los Angeles, Los Angeles, CA USA
| | - Lawrence Mitchell Blatt
- Division of Digestive Diseases, The Pfleger Liver Institute, David Geffen School of Medicine, University of California in Los Angeles, Los Angeles, CA USA
- Alios Biopharma, South San Francisco, CA USA
| |
Collapse
|
167
|
Abstract
Hepatocellular carcinoma (HCC) represents the fifth most common cancer in the world, and the third most frequent oncological cause of death. The incidence of HCC is on the increase. HCC typically develops in patients with chronic liver diseases, and cirrhosis, usually with viral etiology, is the strongest predisposing factor. Nowadays HCC diagnosis is a multistage process including clinical, laboratory, imaging and pathological examinations. The prognosis of HCC is mostly poor, because of detection at an advanced, non-resectable stage. Potentially curative treatment (surgery) is limited and really possible only for cases with small HCC malignancies. For this reason, more effective surveillance strategies should be used to screen for early occurrence of HCC targeted to the population at risk. So far, the generally accepted serological marker is α-fetoprotein (AFP). Its diagnostic accuracy is unsatisfactory and questionable because of low sensitivity, therefore there is a strong demand by clinicians for new HCC-specific biomarkers. In this review, we will focus on other biomarkers that seem to improve HCC diagnosis, such as AFP-L3, des-γ-carboxyprothrombin, α-l-fucosidase, γ-glutamyl transferase, glypican-3, squamous cell carcinoma antigen, a new generation of immunoglobulin M-immunocomplexes, and very promising gene-expression profiling.
Collapse
|
168
|
Mohamadnejad M, Tavangar SM, Sotoudeh M, Kosari F, Khosravi M, Geramizadeh B, Montazeri G, Estakhri A, Mirnasseri MM, Fazlollahi A, Zamani F, Malekzadeh R. Histopathological Study of Chronic Hepatitis B: A Comparative Study of Ishak and METAVIR Scoring Systems. Int J Organ Transplant Med 2010; 1:171-6. [PMID: 25013582 PMCID: PMC4089240] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
Abstract
BACKGROUND Ishak and METAVIR scoring systems are among the most commonly used histopathological systems to evaluate chronic hepatitis. OBJECTIVE To assess the level of agreement between these two scoring systems in patients with chronic hepatitis B. METHODS Liver biopsy samples taken from 92 patients with chronic hepatitis B were considered as the training set; 57 more biopsy specimens were used as the validation set. In the training set, grade of necroinflammation and stage of fibrosis for each liver biopsy specimen were determined by two expert liver pathologists using both Ishak and METAVIR systems. Inter-observer variability between the two pathologists was evaluated. Biopsy specimens of the validation set were seen and scored by a third expert pathologist. In the training set, criteria were developed to categorize Ishak grading and staging systems separately to best fit with the METAVIR scoring system. The criteria found in the training set, was then tested in the validation set. The level of agreement between the two scoring systems was assessed by weighted kappa statistics. RESULTS For the training set, agreement between the two pathologists was excellent. Using our proposed criteria in the training set, there was excellent level of agreement in grading (κ = 0.89) and staging (κ = 0.99) between Ishak and METAVIR systems. In the validation set, the criteria led to substantial correlation (κ = 0.61) in grading, and excellent correlation (κ = 0.94) in staging between the two systems. CONCLUSION Using our proposed criteria, excellent or at least substantial concordance between Ishak and METAVIR scoring systems can be achieved for the degree of both necro-inflammatory changes and fibrosis.
Collapse
Affiliation(s)
- M. Mohamadnejad
- Digestive Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran,
- Gastrointestinal and Liver Disease Research Center, Iran University of Medical Sciences,
| | - S. M. Tavangar
- Departments of Pathology, Shariati Hospital, Tehran University of Medical Sciences, Tehran,
| | - M. Sotoudeh
- Departments of Pathology, Shariati Hospital, Tehran University of Medical Sciences, Tehran,
| | - F. Kosari
- Sina Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran,
| | - M. Khosravi
- Gastrointestinal and Liver Disease Research Center, Iran University of Medical Sciences,
| | - B. Geramizadeh
- Organ Transplant Research Center, Nemazi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran
| | - G. Montazeri
- Digestive Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran,
| | - A. Estakhri
- Digestive Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran,
| | - M. M. Mirnasseri
- Digestive Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran,
| | - A. Fazlollahi
- Digestive Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran,
| | - F. Zamani
- Gastrointestinal and Liver Disease Research Center, Iran University of Medical Sciences,
| | - R. Malekzadeh
- Digestive Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran,
| |
Collapse
|
169
|
Larrubia JR, Benito-Martínez S, Miquel J, Calvino M, Sanz-de-Villalobos E, Parra-Cid T. Costimulatory molecule programmed death-1 in the cytotoxic response during chronic hepatitis C. World J Gastroenterol 2009; 15:5129-40. [PMID: 19891011 PMCID: PMC2773891 DOI: 10.3748/wjg.15.5129] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
Hepatitis C virus (HCV)-specific CD8+ T cells play an important role in the resolution of HCV infection. Nevertheless, during chronic hepatitis C these cells lack their effector functions and fail to control the virus. HCV has developed several mechanisms to escape immune control. One of these strategies is the up-regulation of negative co-stimulatory molecules such us programmed death-1 (PD-1). This molecule is up-regulated on intrahepatic and peripheral HCV-specific cytotoxic T cells during acute and chronic phases of the disease, whereas PD-1 expression is low in resolved infection. PD-1 expressing HCV-specific CD8+ T cells are exhausted with impairment of several effector mechanisms, such as: type-1 cytokine production, expansion ability after antigen encounter and cytotoxic ability. However, PD-1 associated exhaustion can be restored by blocking the interaction between PD-1 and its ligand (PD-L1). After this blockade, HCV-specific CD8+ T cells reacquire their functionality. Nevertheless, functional restoration depends on PD-1 expression level. High PD-1-expressing intrahepatic HCV-specific CD8+ T cells do not restore their effector abilities after PD-1/PD-L1 blockade. The mechanisms by which HCV is able to induce PD-1 up-regulation to escape immune control are unknown. Persistent TCR stimulation by a high level of HCV antigens could favour early PD-1 induction, but the interaction between HCV core protein and gC1q receptor could also participate in this process. The PD-1/PD-L1 pathway modulation could be a therapeutic strategy, in conjunction with the regulation of others co-stimulatory pathways, in order to restore immune response against HCV to succeed in clearing the infection.
Collapse
|
170
|
Sato S, Miyake T, Tobita H, Oshima N, Ishine J, Hanaoka T, Amano Y, Kinoshita Y. A dose-up of ursodeoxycholic acid decreases transaminases in hepatitis C patients. World J Gastroenterol 2009; 15:2782-6. [PMID: 19522030 PMCID: PMC2695895 DOI: 10.3748/wjg.15.2782] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
AIM: To examine whether a dose-up to 900 mg of ursodeoxycholic acid (UDCA) decreases transaminases in hepatitis C patients.
METHODS: From January to December 2007, patients with chronic hepatitis C or compensated liver cirrhosis with hepatitis C virus (HCV) (43-80 years old) showing positive serum HCV-RNA who had already taken 600 mg/d of UDCA were recruited into this study. Blood parameters were examined at 4, 8 and 24 wk after increasing the dose of oral UDCA from 600 to 900 mg/d.
RESULTS: Serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), and gamma-glutamyl transpeptidase (GGT) levels were significantly decreased following the administration of 900 mg/d as compared to 600 mg/d. The decrease in ALT from immediately before the dose-up of UDCA to 8 wk after the dose-up was 14.3 IU/L, while that for AST was 10.5 IU/L and for GGT was 9.8 IU/L. Platelet count tended to increase after the dose-up of UDCA, although it did not show a statistically significant level (P = 0.05). Minor adverse events were observed in 3 cases, although no drop-outs from the study occurred.
CONCLUSION: Oral administration of 900 mg/d of UDCA was more effective than 600 mg/d for reducing ALT, AST, and GGT levels in patients with HCV-related chronic liver disease.
Collapse
|
171
|
Zhang XL, Wang XY, Xie HZ, Ba T. Value of serum biochemical indexes in diagnosis of chronic hepatitis. Shijie Huaren Xiaohua Zazhi 2009; 17:1458-1461. [DOI: 10.11569/wcjd.v17.i14.1458] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
AIM: To evaluate the diagnostic value of serum biochemical indexes and to analyze the pathological progression of chronic hepatitis.
METHODS: Serum biochemical tests, including serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), gamma-glutamy (GGT), albumin (ALB), total bilirubin (TBIL), prothrobin activity (PTA), were conducted in 142 patients with chronic hepatitis, and the results were compared with hepatitis progression (pathological grade and stage).
RESULTS: The levels of ALT, AST, ALB, PTA varied dramatically among different pathological inflammatory grades (F = 6.812, 6.592, 10.131, 3.247, P < 0.05 or 0.01). However, no significant difference in ALT, AST, ALP, GGT, ALB, TBIL, PTA levels was observed at different fibrosis stages. The serum levels of TBIL and PTA were positively related to pathological progression, while the serum level of ALB was negatively related to pathological grades and stages.
CONCLUSION: Serum biochemical indexes including ALT, AST, ALB and PTA could reflect the severity of chronic hepatitis, however, the indexes could not indicate the fibrosis progression of chronic hepatitis.
Collapse
|
172
|
Abstract
Autoimmune hepatitis (AIH) is a chronic hepatitis of unknown etiology which can progress to cirrhosis. Its clinical manifestations are highly variable and sometimes follow a fluctuating course. Diagnosis is based on characteristic histologic, clinical, biochemical and serological findings. Anti-inflammatory/immunosuppressive treatment frequently induces remission but long-term maintenance therapy is often required. Liver transplantation is generally successful in patients with decompensated cirrhosis unresponsive to or intolerant of medical therapy.
Collapse
|
173
|
Zuberi BF, Zuberi FF, Memon SA, Qureshi MH, Ali SZ, Afsar S. Sustained virological response based on rapid virological response in genotype-3 chronic hepatitis C treated with standard interferon in the Pakistani population. World J Gastroenterol 2008; 14:2218-21. [PMID: 18407597 PMCID: PMC2703848 DOI: 10.3748/wjg.14.2218] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
AIM: To document the sustained virological response (SVR) in rapid virological responders (RVR) of genotype-3 chronic hepatitis C with standard interferon (SdIF).
METHODS: Hepatitis C genotype-3 patients during the period July 2006 and June 2007 were included. Complete blood counts, prothrombin time, ALT, albumin, qualitative HCV RNA were done. SdIF and ribavirin were given for 4 wk and qualitative HCV RNA was repeated. Those testing negative were allocated to group-A while the rest were allocated to group-B. Treatment was continued a total of 16 and 24 wk for group A and B respectively. HCV RNA was repeated after 24 wk of treatment. End virological and sustained virological responses were compared by χ2 test. ROC of pretreatment age, ALT and albumin were plotted for failure to achieve SVR.
RESULTS: Of 74 patients treated, RCV RNA after 16 wk of therapy became undetectable in 34 (45.9%) and was detectable in 40 (54.1%) and were allocated to groups A and B respectively. SVR was achieved in 58.8% and 27.8% in groups A and B respectively. SVR rates were significantly higher in patients who had RVR as compared to those who did not (P = 0.0; γ = 2). Both groups combined ETR and SVR were 70% and 33% respectively. ROC plots of pretreatment age, ALT and albumin for SVR showed only ALT to have a significantly large area under the curve.
CONCLUSION: SVR rates were higher in patients who had RVR with SdIF and high pre treatment ALT values correlated to probability of having RVR.
Collapse
|
174
|
Zhong CF, Hao W, Li Z, Meng X, Yan Y, Niu JQ, Yin JM. Relationship between the histology and genotype of hepatitis B virus DNA in chronic hepatitis B patients. Shijie Huaren Xiaohua Zazhi 2007; 15:1859-1864. [DOI: 10.11569/wcjd.v15.i16.1859] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
AIM: To investigate the relationship between hepatitis B virus DNA genotype and pathological changes in patients with chronic hepatitis B.
METHODS: A total of 92 chronic hepatitis B (CHB) patients were tested for HBV genotype and sub-genotypes by nested and fluorescence quantitative polymerase chain reactions, respectively. Liver biopsy specimens of all patients were taken and histological activity index (HAI) necroinflammation (HAI-NI), and fibrosis (HAI-F) scores were calculated.
RESULTS: Among the 92 cases, 17 (18.48%) had genotype B (sub-genotype B2), 17 (18.48%) had mixed B/C genotype (sub-genotype B2/Ca) and 58 (63.04%) had C (sub-genotype Ca) infections. In the 17 CHB patients with genotype B, HAI-NI were 35.29%, 58.82% and 5.88% for G1, G2 and G3, respectively, HAI-F scores were 58.82%, 29.41% and 11.76% for S1, S2, and S3, respectively; In the 17 cases with mixed B/C genotype infection, HAI-NI were 35.29%, 52.94% and 11.76% for G1-G3, respectively, HAI-F were 23.52%, 52.94%, 23.52% for S1-S3, respectively; In the 58 patients with genotype C, HAI-NI was 31.03%, 24.14%, 36.21% and 8.62% for G1-G4, respectively, HAI-F were 25.86%, 39.66%, 5.17%, 29.31% for S1-S4, respectively. There were significantly differences in the HAI-NI and HAI-F scoring in patients with different HBV genotypes (χ2 = 15.13, P < 0.01). The ages of CHB patients were significantly different between the HBV genotypes C and B. The frequencies were 58%-76% for those 21-30 years old, 17.6%-29.4% for 31-40 in genotype B, and 25% for 21-30 years old, 46.6% for 31-40, and 24.24% for >40 in genotype C (χ2 = 9.54, P < 0.05).
CONCLUSION: The most common HBV genotype was C. Patients with HBV C had severer infections than those of other genotypes. Further, different HBV genotypes infected different ages of HBV patients.
Collapse
|
175
|
Abstract
AIM: To investigate the factors contributing to health-related quality of life (HRQL) in chronic liver disease (CLD).
METHODS: Patients with CLD and age- and sex-matched normal subjects performed the validated Thai versions of the short-form 36 (SF-36) by health survey and chronic liver disease questionnaire (CLDQ). Stepwise multiple regression analysis was used to assess the impact of disease severity, demography, causes of CLD, socioeconomic factors, and self-rating health perception on HRQL.
RESULTS: Two-hundred and fifty patients with CLD and fifty normal subjects were enrolled into the study. Mean age and the numbers of low educated, unemployed, blue-collar career and poor health perception increased significantly from chronic hepatitis to Child’s Classes A to B to C. Advanced stage of CLD was related to deterioration of HRQL. Increasing age and female reduced physical health area. Low socioeconomic factors and financial burden affected multiple areas of HRQL. In overall, the positive impact of self-rating health perception on HRQL was consistently showed.
CONCLUSION: Advanced stages of chronic liver disease, old age, female sex, low socioeconomic status and financial burden are important factors reducing HRQL. Good health perception improves HRQL regardless of stages of liver disease.
Collapse
Affiliation(s)
- Abhasnee Sobhonslidsuk
- Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, 270 Praram 6 road, Rajathevee, Bangkok 10400, Thailand.
| | | | | | | | | | | |
Collapse
|
176
|
Quan CJ, Jin RS, Piao DM. Expression of proliferating cell nuclear antigen and Ki-67 antigen in liver tissues of cirrhotic patients. Shijie Huaren Xiaohua Zazhi 2006; 14:3151-3154. [DOI: 10.11569/wcjd.v14.i32.3151] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
AIM: To investigate the expression and significances of proliferating cell nuclear antigen (PCNA) and Ki-67 antigen in liver tissues of cirrhotic patients.
METHODS: SP immunohistochemical technique was performed to detect the expression of PCNA and Ki-67 in 58 liver specimens from patients with cirrhosis from hepatitis B (n = 24) and hepatitis C (n = 22), and chronic hepatitis (n = 12), and the labeling index (LI) of the positive cells was also determined. Sirius red staining was used to determine the area density of collagen in liver tissues.
RESULTS: The expression of PCNA and Ki-67 LI was significantly higher in chronic hepatitis than that in cirrhosis (34.67% ± 8.6% vs 10.38% ± 3.76%, P < 0.001; 2.81% ± 0.51% vs 1.69% ± 1.03%, P < 0.001), and moreover, they were markedly higher in hepatitis C-induced cirrhosis than those in hepatitis B-induced one (13.12% ± 1.42% vs 6.32% ± 2.18%, P < 0.001; 2.48% ± 0.54% vs 0.95% ± 0.77%, P < 0.001). The area density of collagenous fiber was significantly increased in cirrhosis than that in chronic hepatitis (12.0 ± 3.1 vs 1.40 ± 1.0, P < 0.001), but there was no difference between the two types of cirrhosis (P > 0.05). The area density of collagenous fiber had no significant correlation with the LI values of PCNA and Ki-6 in cirrhosis (P > 0.05).
CONCLUSION: The proliferation rate of liver cells is lower in cirrhosis than that in chronic hepatitis, but it is higher in cirrhosis from hepatitis C than that in the one from hepatitis B. There is no significant correlation between the area density of collagenous fiber and the expression of PCNA and Ki-67.
Collapse
|
177
|
Abstract
AIM: To investigate reactivated Epstein-Barr virus (EBV) infection as a cause for chronic hepatitis.
METHODS: Patients with occasionally established elevated serum aminotransferases were studied. HIV, HBV and HCV-infections were excluded as well as any other immunosuppressive factors, metabolic or toxic disorders. EBV viral capsid antigen (VCA) IgG and IgM, EA-R and EA-D IgG and Epstein-Barr nuclear antigen (EBNA) were measured using IFA kits. Immunophenotyping of whole blood was performed by multicolor flow cytometry. CD8+ T cell responses to EBV and PHA were determined according to the intracellular expression of IFN-γ.
RESULTS: The mean alanine aminotransferase (ALT) and gamma glutamyl transpeptidase (GGTP) values exceeded twice the upper normal limit, AST/ALT ratio < 1. Serology tests showed reactivated EBV infection in all patients. Absolute number and percentages of T, B and NK cells were within the reference ranges. Fine subset analysis, in comparison to EBV+ healthy carriers, revealed a significant decrease of naive T cells (P < 0.001), accompanied by increased percentage of CD45RA- (P < 0.0001), and terminally differentiated CD28-CD27-CD8+ T cells (P < 0.01). Moderately elevated numbers of CD38 molecules on CD8+ T cells (P < 0.05) proposed a low viral burden. A significantly increased percentage of CD8+ T cells expressing IFN-γ in response to EBV and PHA stimulation was registered in patients, as compared to controls (P < 0.05). Liver biopsy specimens from 5 patients revealed nonspecific features of low-grade hepatitis.
CONCLUSION: Chronic hepatitis might be a manifestation of chronic EBV infection in the lack of detectable immune deficiency; the expansion of CD28-CD27- and increase of functional EBV-specific CD8+ T cells being the only surrogate markers of viral activity.
Collapse
Affiliation(s)
- Mihaela Petrova
- Clinic of Gastroenterology, Medical Institute Ministry of Interior, Skobelev 79, Sofia 1606, Bulgaria.
| | | | | | | | | | | | | |
Collapse
|
178
|
Abstract
AIM: To evaluate the prevalence of isolated anti-HBc in patients with chronic hepatitis C virus (HCV) infection, and its relation to disease severity.
METHODS: We screened all patients with chronic HCV infection referred to King Faisal Specialist Hospital and Research Center for hepatitis B surface antigen (HBsAg), antibody to hepatitis B surface antigen (anti-HBs), and anti-HBc. One hundred and sixty nine patients who tested negative for both HBsAg and anti-HBs were included in this study.
RESULTS: Pathologically, 59 had biopsy-proven cirrhosis and 110 had chronic active hepatitis (CAH). Of these 169 patients, 85 (50.3%) tested positive for anti-HBc. Patients with CAH had significantly higher prevalence of isolated anti-HBc than patients with cirrhosis, 71 (64.5%) and 14 (23.7%) respectively (P < 0.001). Twenty-five patients were tested for HBV DNA by qualitative PCR. The test was positive in 3 of them (12%; occult HBV infection).
CONCLUSION: Isolated anti-HBc alone is common in Saudi patients with chronic HCV infection, and is significantly more common in those with CAH than those with cirrhosis. Therefore, a screening strategy that only tests for HBsAg and anti-HBs in these patients will miss a large number of individuals with isolated anti-HBc, who may be potentially infectious.
Collapse
Affiliation(s)
- Ahmed Helmy
- Department of Liver Transplantation, Hepatobiliary and Pancreatic Surgery, King Faisal Specialist Hospital and Research Center, Riyadh 11211, Saudi Arabia.
| | | |
Collapse
|
179
|
Hong YM, Zhu YF, Wu AH, Hou JL. Relationship between serum lipid level and pathological grading and staging in chronic hepatitis B patients. Shijie Huaren Xiaohua Zazhi 2006; 14:453-456. [DOI: 10.11569/wcjd.v14.i4.453] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
AIM: To investigate the relationship between the severity of liver histology and serum lipid level in patients with chronic hepatitis B.
METHODS: The serum levels of total cholesterol (TC), triglycerides (TG), high density lipoprotein-cholesterol (HDL-C), low density lipoprotein-cholesterol (LDL-C), and low density lipoprotein-cholesterol (VLDL-C) was measured and compared in 130 chronic hepatitis B patients and 30 healthy controls with automatic biomedical analyzer.
RESULTS: The levels of serum lipid were decreased with the enhancement of histological inflammation grading and fibrosis staging, and they were significant ly different in patients with G3, G4 grades (for inflammation degree) and S4 stage (for fibrosis degree) than those in the controls (P < 0.05 or P < 0.01). The levels of serum lipid in patients with G1, G2 grades and S0, S1, S2, S3 stages had no marked difference with those in the controls.
CONCLUSION: The levels of serum lipid are useful for the judgment of the severe hepatic inflammation and prognosis.
Collapse
|
180
|
Thakeb F, El-Serafy M, Zakaria S, Monir B, Lashin S, Marzaban R, El-Awady M. Evaluation of liver tissue by polymerase chain reaction for hepatitis B virus in patients with negative viremia. World J Gastroenterol 2005; 11:6853-7. [PMID: 16425396 PMCID: PMC4725047 DOI: 10.3748/wjg.v11.i43.6853] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
AIM: To assess the clinical significance of Hepatitis B virus (HBV) DNA localization in the liver tissue of patients with positive HBsAg and negative viremia.
METHODS: HBV virological parameters of 33 HBsAg positive chronic hepatitis patients, including seromarkers and HBV DNA amplification in both sera and liver biopsies, were evaluated.
RESULTS: Ten patients had negative viremia and positive HBV DNA in their liver biopsies. Most of them had HBeAg-negative/HBeAb-positive chronic hepatitis. Their liver biochemical and histopathological profiles were different from the viremic patients. Their disease pattern was designated as “hepatitis B in situ”.
CONCLUSION: Hepatitis B in situ is a consequential entity which can be missed in clinical practice. It is a new clinical pattern of chronic HBV infection that considers HBV in liver biopsy and adds a new indication for antiviral therapy.
Collapse
Affiliation(s)
- Fouad Thakeb
- Tropical Medicine Department, Cairo University, Cairo, Egypt
| | | | | | | | | | | | | |
Collapse
|
181
|
Huang ZM, Huang QW, Qin YQ, Huang CH, Qin HJ, Zhou YN, Xu X, Lu CL. Clinical characteristics and distribution of hepatitis B virus genotypes in Guangxi Zhuang population. World J Gastroenterol 2005; 11:6525-9. [PMID: 16425428 PMCID: PMC4355798 DOI: 10.3748/wjg.v11.i41.6525] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
AIM: To investigate the distribution of HBV genotypes and their YMDD mutations in Guangxi Zhuang population, China, and to study the relationship between HBV genotypes and clinical types of HB, ALT, HBV DNA, HBe system as well as the curative effect of Lamivudine (LAM) on hepatitis B.
METHODS: A total of 156 cases were randomly chosen as study subjects from 317 patients with chronic hepatitis B (CHB). HBV genotypes were determined by PCR-microcosmic nucleic acid cross-ELISA. YMDD mutations were detected by microcosmic nucleic acid cross-nucleic acid quantitative determination. HBV DNA was detected by fluorescence ratio PCR analysis. LAM was given to 81 cases and its curative effect was observed by measuring ALT, HBV DNA load, HBeAg, and HBeAg/HBeAb conversion rate.
RESULTS: HBV genotypes B, C, D, and non-classified genotypes were found in Guangxi Zhuang population. accounting for 25.6%, 47.4%, 58.3%, and 16.0%, respectively. Seventy-four cases were CD-, CB-, BD-mixed genotypes (47.7%). Forty-six (29.5%) cases had YMDD mutations. Genotype B was mostly found in mild and moderate CHB patients. Genotypes C, D and mixed genotype mostly occurred in severe CHB cases. Genotypes D and CD HBV-infected patients had higher ALT and HBV DNA than patients with other types of HBV infection. There was no significant difference among the genotypes in YMDD mutations, clinical types, ALT and HBV DNA level. Non-classified types geno had a significantly lower positive rate of HBeAg than other genotypes (χ2=12.841, P<0.05). There was no significant difference in ALT recovery rate, HBV DNA load, HBeAg, and HBeAg/HBeAb conversion rate, 48 wk after LAM treatment between groups of genotypes D, CD, and non-classified type.
CONCLUSION: Genotypes B, C, and D, non-classified and mixed genotype of HBV are identified in the Guangxi Zhuang population. Variations in genotypes are associated with clinical severity and serum ALT levels, but not with YMDD mutation or HBV DNA load. Therapeutic effects of LAM on clinical parameters are not influenced by differences in genotypes. Further studies are needed to gain an in-depth understanding of the relationship between HBV genotypes and serum HBeAb and HBeAg.
Collapse
Affiliation(s)
- Zhong-Min Huang
- Department of Infectious Diseases, The Affiliated Hospital of Youjiang Medical College for Minority Nationalities, Baise 533000, Guangxi Zhuang Autonomous Region, China.
| | | | | | | | | | | | | | | |
Collapse
|
182
|
Spadaro A, Ajello A, Morace C, Zirilli A, D'arrigo G, Luigiano C, Martino F, Bene A, Migliorato D, Turiano S, Ferraù O, Freni MA. Serum chromogranin-A in hepatocellular carcinoma: Diagnostic utility and limits. World J Gastroenterol 2005; 11:1987-90. [PMID: 15800991 PMCID: PMC4305722 DOI: 10.3748/wjg.v11.i13.1987] [Citation(s) in RCA: 42] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
AIM: The utility of serum alpha-fetoprotein (α-FP) for the detection of hepatocellular carcinoma (HCC) is questionable. High serum levels of chromogranin-A (CgA) have recently been reported in HCC. Impaired hepatic, renal, and heart functions influence circulating CgA. The aim of this study was to assess sensitivity and specificity of serum CgA as a marker of HCC in patients with liver cirrhosis (LC).
METHODS: Serum CgA levels were measured by RIA in 339 patients of which 54 HCC, 132 LC, 45 chronic hepatitis (CH), 27 chronic heart failure (CHF), 36 chronic renal failure (CRF), 45 chronic inflammatory bowel disease (IBD) as disease controls and in 75 healthy controls. Patients with liver disease or IBD and concomitant renal and/or heart failure were excluded. Pearson correlation, non-parametric combination test and confidence interval analysis were used for statistical analysis.
RESULTS: Serum CgA above normal values (100 ng/mL) were found in 83% of HCC patients, in 48% of LC patients, in 20% of CH patients, in 33% of IBD patients, in 92% of CRF patients, in 100% of CHF patients, and in none of the healthy controls. The mean CgA values in HCC (769±1 046), in LC (249±369), in CH (87±94), in CRF (1390±1401), in CHF (577±539), in IBD (146±287) were significantly higher than those in healthy controls (48±18). HCC patients had higher CgA values (P<0.01) than LC, CH, and IBD patients but did not differ from those with CRF or CHF. The 95% CI for the mean (250-1289 ng/mL) in HCC patients was selected as a CgA range and the lower value of such range was assumed as cut-off. Sensitivity and specificity of CgA, calculated in relation to the cut-off in patients with cirrhosis and HCC, were respectively 61% (CI 48-73%) and 82% (CI 75-88%). Serum α-FP values were >200 ng/mL in 21% of the HCC patients and in none of the LC patients. No significant correlation was found between α-FP and CgA in patients with HCC and in patients with cirrhosis.
CONCLUSION: When HCC is suspected and α-FP is normal or <200 ng/mL, CgA serum values represent a complementary diagnostic tool, unless kidney or heart failure is present.
Collapse
Affiliation(s)
- Aldo Spadaro
- Dipartimento Clinico Sperimentale di Medicina e Farmacologia, Università di Messisna, 98125 Messina, Italy.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
183
|
Abstract
AIM: To determine the complex of AST and immunoglobulin and to investigate its clinical significance in patients with liver disease.
METHODS: The complex of AST and immunoglobulin was determined by encounter immunoelectrophoresis and its clinical significance was investigated in 128 patients with liver disease.
RESULTS: AST was bound to immunoglobulin of anti-immunoglobulin A (IgA) class, but any binding to anti-immunoglobulin G and anti-immunoglobulin M classes was not observed. Although the incidence of AST–immunoglobulin complex was 41.8% in chronic hepatitis (CH), the incidences in liver cirrhosis and hepatocellular carcinoma were 62.2 and 90.0%, respectively. In alcoholic liver disease with high level of serum IgA, the incidence of the complex was 66.7%, which was higher than that in CH. The ratio of binding to lambda-chain of IgA was higher than that to kappa-chain of IgA. The serum level of IgA and the ratio of AST/alanine aminotransferase (ALT) were significantly higher in patients with AST–IgA complex than in those without complex.
CONCLUSION: These results suggest that AST–IgA complex in patients with progressive liver diseases and alcoholic liver injury can lead to elevation of the ratio of AST/ALT.
Collapse
Affiliation(s)
- Masahiko Tameda
- First Department of Internal Medicine, School of Medicine, Mie University, Edobashi 2-174, Tsu, Mie 514-8507 Japan
| | | | | | | | | | | | | |
Collapse
|
184
|
Abstract
AIM: To polymerase P region (YMDD) mutations of hepatitis B virus gene (HBV DNA) in patients with chronic hepatitis B (CHB) untreated with antiviral medicines and to explore its correlation with pre-c-zone mutations, HBV genotypes and HBV DNA level, and to observe its curative effect.
METHODS: A total of 104 cases (38 cases in group of familial aggregation and 66 cases in group of non-familial aggregation) were randomly chosen from 226 patients with CHB who did not receive the treatment of lamivudine (LAM) and any other antivirus drugs within the last one year. Their serum YMDD mutations were detected by microcosmic nucleic acid and cross-nucleic acid quantitative determination, HBV genotypes by PCR-microcosmic nucleic acid cross-ELISA, HBV DNA quantitative determination and fluorescence ration PCR analysis, hepatitis B virus markers (HBVM) by ELISA. LAM was taken by 10 patients with YMDD mutations and its curative effect was observed.
RESULTS: Twenty-eight cases (26.9%) had YMDD mutations, of them 11 cases (28.9%) were in familial aggregation group (38 cases) and 17 cases (25.8%) in non-familial aggregation group (66 cases) with no significant difference between the two groups. Twenty-seven point one percent (16/59) cases were positive for HBeAg YMDD mutations, and 26.7% (12/45) cases were negative for HBeAg and positive for anti-HBe. There was also no significant difference between the two groups. Different YMDD incidence rate existed in different HBV genotypes. HBV DNA level did not have a positive correlation with the incidence of YMDD mutations. LAM was effective for all patients with mutations.
CONCLUSION: Wild mutant strains in HBV and their incidence rate have no significant difference between familial aggregation and non-familial aggregation. It may have no significant relationship between YMDD mutations and pre-c-zone mutations. HBV DNA level may not have a positive correlation with YMDD mutations. LAM is clinically effective for CHB patients with YMDD mutations.
Collapse
Affiliation(s)
- Zhong-Min Huang
- Department of Infectious Diseases, The Affiliated Hospital of YouJiang Medical College for Nationalities, Baise 533000, Guangxi Zhuang Autonomous Region, China.
| | | | | | | | | | | | | | | |
Collapse
|
185
|
Fernández I, Castellano G, de Salamanca RE, Colina F, de la Cámara AG, Morán MJ, Muñoz R, Solís-Herruzo JA. Porphyria cutanea tarda as a Predictor of Poor Response to Interferon Alfa Therapy in Chronic Hepatitis C. Scand J Gastroenterol 2003; 38:314-319. [PMID: 28248596 DOI: 10.1080/00365520310000672a] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
BACKGROUND Porphyria cutanea tarda (PCT) is sometimes associated with hepatitis C virus chronic infection. The aim of this study was to describe the effect of interferon alfa (IFN-a) in the treatment of patients with chronic hepatitis C and PCT. METHODS We treated a total of 66 patients with chronic hepatitis C with IFN-a 2b (5 MU t.i.w.) for 12 months. Twenty-two of these patients suffered from PCT as well. These patients differed from patients without PCT in that they were men, past history of alcohol abuse and HFE gene mutations were more common and the source of infection was almost always unknown. RESULTS Sustained virologie response was obtained in 19.7% of the 66 treated patients, 27.3% in the non-PCT group and 4.5% in the PCT group (P < 0.05). This difference could not be ascribed to the difference in sex of patients, history of alcohol abuse, HCV genotype or iron status. CONCLUSION Multivariate logistic regression analysis revealed that PCT is independently and significantly associated with non-sustained response to IFNa therapy. In conclusion, patients with chronic hepatitis C and PCT rarely responded to IFNa treatment.
Collapse
Affiliation(s)
- I Fernández
- a Depts. of Gastroenterology, Unit for the Study of Porphyrias, Pathology and Clinical Epidemiology , Hospital Universitario '12 de Octubre' , Madrid , Spain
| | - G Castellano
- a Depts. of Gastroenterology, Unit for the Study of Porphyrias, Pathology and Clinical Epidemiology , Hospital Universitario '12 de Octubre' , Madrid , Spain
| | - R E de Salamanca
- a Depts. of Gastroenterology, Unit for the Study of Porphyrias, Pathology and Clinical Epidemiology , Hospital Universitario '12 de Octubre' , Madrid , Spain
| | - F Colina
- a Depts. of Gastroenterology, Unit for the Study of Porphyrias, Pathology and Clinical Epidemiology , Hospital Universitario '12 de Octubre' , Madrid , Spain
| | - A Gómez de la Cámara
- a Depts. of Gastroenterology, Unit for the Study of Porphyrias, Pathology and Clinical Epidemiology , Hospital Universitario '12 de Octubre' , Madrid , Spain
| | - M J Morán
- a Depts. of Gastroenterology, Unit for the Study of Porphyrias, Pathology and Clinical Epidemiology , Hospital Universitario '12 de Octubre' , Madrid , Spain
| | - R Muñoz
- a Depts. of Gastroenterology, Unit for the Study of Porphyrias, Pathology and Clinical Epidemiology , Hospital Universitario '12 de Octubre' , Madrid , Spain
| | - J A Solís-Herruzo
- a Depts. of Gastroenterology, Unit for the Study of Porphyrias, Pathology and Clinical Epidemiology , Hospital Universitario '12 de Octubre' , Madrid , Spain
| |
Collapse
|